NeurosciencebioRxivPreprint
Antibody-based immunotherapy targeting FAM19A5 reverses synaptic loss and improves cognitive function in Alzheimer's disease.
Hanbyul Kim, Sangjin Yoo, Hoyun Kwak…·Jae Young Seong
This paper shows that targeting FAM19A5 with a monoclonal antibody improves synaptic function and cognition in Alzheimer's disease models.